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Background: G-quadruplex forming DNA of gene promoter associated with cell death and growth arrest.
Results: G-quadruplex forming DNA at c-Myc promoter Pu27 destabilizes proteins at telomere and inhibits DNA repair
molecules.
Conclusion: Pu27 shows extensive DNA damage primarily at telomere that contributes to cell death.
Significance: Learning how Pu27 destabilizes at telomeric region is crucial to understanding G-quadruplex-mediated cancer
biology.
Quadruplex-forming DNA sequences are present throughout
the eukaryotic genome, including in telomeric DNA. We have
shown that the c-Myc promoter quadruplex-forming sequence
Pu-27 selectively kills transformed cells (Sedoris, K. C., Thomas,
S. D., Clarkson, C. R., Muench, D., Islam, A., Singh, R., and Miller,
D. M. (2012) Genomic c-Myc quadruplex DNA selectively kills leu-
kemia. Mol. Cancer Ther. 11, 66–76). In this study, we show that
Pu-27 induces profound DNA damage, resulting in striking chro-
mosomal abnormalities in the form of chromatid or chromosomal
breaks, radial formation, and telomeric DNA loss, which induces
-H2AX in U937 cells. Pu-27 down-regulates telomeric shelterin
proteins, DNA damage response mediators (RAD17 and RAD50),
double-stranded break repair molecule 53BP1, G2 checkpoint reg-
ulators (CHK1 and CHK2), and anti-apoptosis gene survivin. Inter-
estingly, there are no changes of DNA repair molecules H2AX,
BRCA1, and the telomere maintenance gene, hTERT. B-U937,
where U937 cells stably transfected with deleted basic domain of
TRF2 is partially sensitive to Pu-27 but exhibits no changes in
expression of shelterin proteins. However, there is an up-regula-
tion of CHK1, CHK2, H2AX, BRCA1, and survivin. Telomere dys-
function-induced foci assay revealed co-association of TRF1with
-H2AX in ATM deficient cells, which are differentially sensitive
to Pu-27 than ATM proficient cells. Alt (alternating lengthening of
telomere) cells are relatively resistant to Pu-27, but there are no
significant changes of telomerase activity in both Alt and non-Alt
cells. Lastly, we show that this Pu-27-mediated sensitivity is p53-
independent. The data therefore support two conclusions. First,
Pu-27 induces DNA damage within both telomeric and nontelo-
meric regions of the genome. Second, Pu-27-mediated telomeric
damage is due, at least in part, to compromise of the telomeric
shelterin protein complex.
G-quadruplex-forming2 sequences are present in the
genomes of all species that have been studied (1–3). These
sequences occur naturally in the telomeres as well as promoter
regions (4 – 6). The Pu-27 sequence is a part of the nuclease
hypersensitivity element III1 element of the c-Myc promoter
that controls 85–90% of c-Myc transcription. Pu-27 is a Gly/
Cys-rich sequence that forms an intramolecular DNA quadru-
plex structure, which later results in c-Myc silencing. A sub-
stantial proportion (80%) of c-Myc expression is regulated by
the nuclease hypersensitivity element III1 element, of which
Pu-27 is a critical part. An oligonucleotide encoding this
sequence, Pu-27, has been shown to inhibit the proliferation of
tumor cells derived from different tissues including breast,
lung, and blood. The Pu-27 oligonucleotide forms a stable
G-quadruplex structure, as demonstrated by circular dichro-
ism. We believe that this characteristic contributes to its non-
antisense growth inhibitory effects.
In addition to G-quadruplexes scattered throughout the
genome, putative quadruplex-forming sequences are found in
the telomeres and are believed to be crucial for the preservation
of chromosome stability (7). The structural characteristics of
the telomere, including protein binding and DNA secondary
structure, prevent their recognition as DNA double-stranded
breaks (DSBs) (8). The telomeric repeat binding factor 2 (TRF2)
plays a crucial role in protecting chromosome ends against
instability (9 –11). TRF2 binds directly to telomeric DNA and
co-associates with five other proteins (TRF1, TIN2, TPP1,
POT1, and Rap1), forming a nucleoprotein complex called
“shelterin” (12). Multiple lines of evidence suggest that TRF2
protects the human telomere from inappropriate end to end
fusions (11, 13). The TRF2 N-terminal domain, which includes
the basic domain of TRF2, condenses the telomeric end by
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inserting a negative torsion, stimulates the invasion of telo-
meric single strand DNA inside a homologous duplex (1), and
favors telomeric loop formation (11).
Eukaryotic cells have evolved a complex, multidimensional
response to DNA damage (14). When cells sense DNA damage
or replication arrest, cell cycle checkpoints are activated that
lead to cell cycle arrest. This, in turn, buys time for repair before
the DNA damage can be passed on to daughter cells. In addition
to checkpoint activation, the DNA damage response induces
transcriptional machinery, improves DNA repair pathways
and, if the level of damage is severe, initiates cell death (15). All
of these processes are tightly regulated so that the genetic mate-
rial can be accurately maintained and replicated within the cell.
An important component of this complex response to DNA
damage is the ATM (ataxia-telangiectasia mutated) gene,
which belongs to the phosphoinositol 3-kinase family (16 –18).
ATM is primarily activated following DNA DSB by autophos-
phorylation of its serine residue 1981 (19, 20). This, in turn,
leads to the phosphorylation of multiple downstream proteins
which are involved in DNA damage recognition, cell cycle
arrest, and apoptosis such as p53, H2AX, CHK2, and Smc1 (21).
ATM is considered to be one of the main transducers of the
telomere damage signal arising from telomeric erosion during
senescence (22). TRF2 was reported to be a direct inhibitor of
ATM at the telomere (23, 24). Mutations in ATM lead to faulty
telomere maintenance in mammalian cells (16). ATM influ-
ences the interaction between telomeres and the nuclear
matrix. Therefore, alteration in telomere chromatin could be at
least partly responsible for the pleiotropic phenotype of the
ATM gene defect (25). There is also evidence that ATM is
recruited to the telomere during the G2 phase of cell cycle. It has
been suggested that telomere ends need to be recognized as
DNA damage to complete telomere replication and to acquire a
structure that is essential for proper function (26 –28). How-
ever, the exact role of ATM at telomeres remains largely
unclear because of its multiple functions. It is particularly chal-
lenging to distinguish a possible role in telomere replication
from its role at dysfunctional telomeres and in induction of cell
checkpoints, repair, and apoptosis. It has been proposed that
the replication fork is buried in telomeres leading to a transient
ATM and ATR/ATM DNA damage response, which is not
enough to stop cell propagation but probably is required for
proper telomere processing (26).
In this study, we demonstrate that Pu-27 somehow causes
extensive DNA damage, inducing a brisk DNA damage
response. We explore the important role of the various mole-
cules involved in DNA damage response in Pu-27-induced cell
death.
EXPERIMENTAL PROCEDURES
Cells and Cell Culture—Human histiocytic lymphoma U937
cells (ATCC) and human colon carcinoma HCT 116 p53/,
HCT116 p53/, and HCT p53/ cells were bought from the
Core Cell Center of Johns Hopkins University, ATM mouse
wild type, and null (334 ATM/, 4a ATM/, and 695 
743/) cells (gift from MS Turker, Oregon Health Science
University, Portland, OR), and lung adenocarcinoma cell lines
A549 and Sk-Lu-1 (obtained from ATCC) were maintained in
RPMI or DMEM supplemented with 10% FCS. 5  104 cells
were plated in 6-well plates and treated with 10 M of Pu-27 or
control cytosine-rich oligonucleotide (CRO) next day. The cells
were harvested for respective assay on different days.
Western Blots—After treatments, the cells were lysed in mod-
ified radioimmune precipitation assay buffer (9 mM urea, 75 mM
Tris, pH 7.5, 150 mM NaCl, 0.5% sodium deoxicolate, 1 mM
EDTA) placed on ice for 30 min. During this time, cells were
mixed by inverting the tube several times every 10 min. Extracts
were centrifuged at 12,000 rpm with a table top centrifuge for
10 min to sediment insoluble material. Lysates were quanti-
tated using Bio-Rad BSA protein assay, and 10 –20-g quanti-
ties of proteins were separated on 10% or 15% bis-acrylamide
gels and then transferred onto PVDF membranes. Proteins
were visualized using TRF2 (Novus Biological), H2AX, and
-actin (Sigma) antibodies. After treatment with Pu-27 and
mutated Pu-27, the cells were lysed at the indicated time with
radioimmune precipitation assay buffer.
Transfection—Transfection of U937 human histiocytic lym-
phoma cancer cell was conducted by electroporation (29, 30) in
nonsupplemented medium at 280 V and 960 microfarads by
means of a Gene Pulser system and a 0.4-cm electrode gap in
Gene Pulser cuvettes (Bio-Rad). Cells in the initial log phase of
growth were harvested by centrifugation, washed once with
medium, and resuspended at room temperature to a concen-
tration of 4  107 cells/0.4 ml. Aliquots of 0.4 ml of cells were
transfected with 2 g of the plasmid pLPC TRF2 B (Addgene),
which contains the TRF2 gene in which the basic domain of
amino acids 1– 44 is deleted. Electroporated cells were incu-
bated at 37 °C overnight, and stably transfected cells were
selected and maintained with puromycin (1 g/ml). Expression
was checked by Western blotting.
Immunofluorescence Staining—Cells were fixed in 4% form-
aldehyde and permeabilized in 0.1% Triton X-100 in 0.02% BSA
in PBS for 2 min at room temperature. For immunolabeling
experiments, cells were blocked in 20% goat serum with 2%
bovine serum albumin in PBS for 15 min at room temperature,
incubated with primary antibody, washed in 0.2% in PBS and
incubated with the following secondary antibodies: goat anti-
rabbit Alexa-546 (Fig. 3B, red) and goat anti-mouse Alexa-488
(Fig. 3B, green). Nuclei were visualized using DAPI by confocal
analysis obtained with a Zeiss LSM 510 META Laser Scanning
Microscope (Zeiss, Oberkochen, Germany).
MTT Cell Proliferation Assay—The cells were seeded into
96-well plates (Corning, Lowell, MA) at 1500 cells/well. Twenty-
four hours after cells were seeded, different concentrations of
Pu27 and CRO dissolved in water were added to the medium
directly for an additional 96 h. MTT (5 mg/ml; Sigma) was
added to each well. After a 4-h incubation, reduced MTT was
solubilized in 10% SDS, 0.1 N HCl) plate reader. Background
absorbance of the medium in the absence of cells was sub-
tracted. All samples were assayed in triplicate, and the mean for
each experiment was calculated.
Measurement of Telomerase Activity—Telomerase activity in
U937, B-U937, A549, and SL-Lu-1 was detected using a quan-
titative telomerase detection kit (Allied Biotech, Inc., German-
town, MD) according to the manufacturer’s protocol. The assay
is based on PCR amplification of the telomeric DNA. Briefly, 1
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mg of cell extract from 1  105 cells of different cell line was
added telomeric repeats (TTAGGG) onto the 3 end of the sub-
strate oligonucleotide and quantitative telomerase detection
premix and was amplified with a 7500 fast real time machine
(Allied Biotech, Inc.). The PCR products were detected by
measuring the increase in fluorescence caused by the binding of
SYBR Green to double-stranded DNA. A heat-inactivated cell
extract served as a negative control. The real time PCR condi-
tions were as follows: telomerase reaction for 20 min at 25 °C,
PCR initial activation step for 10 min at 95 °C, followed by 35
cycles of denaturation for 30 s at 95 °C, annealing for 30 s at
60 °C, and extension for 30 s at 72 °C.
Annexin V/PI Analyses for Cell Death/Apoptosis—Apoptotic
cells were measured using an annexin V-FITC/propidium
iodide (PI) kit (BioVision, Palo Alto, CA) and detected by flow
cytometry according to the manufacturer’s protocol. Briefly,
after 4 and 5 days of treatment with Pu-27, the cells were har-
vested, collected, resuspended in binding buffer (pH 7.5, 10 mM
HEPES, 2.5 mM CaCl2, and 140 mM NaCl), incubated with
annexin V-FITC/PI for 10 min in the dark, and then analyzed by
flow cytometry. Early stage apoptotic cells stain positive for
annexin V-FITC, whereas those in the late stages of apoptosis
or necrosis stain positive for both annexin V-FITC and PI. The
data were analyzed using the Modfit and Cell Quest software
programs (Becton, Dickinson and Company).
H2AX Detection by Flow Cytometry—Measurement of
H2AX phosphorylation was performed by anti-phospho-his-
tone H2AX (Ser139), clone JBW301, FITC conjugate (Milli-
pore, Temecula, CA). U937 and B-U937 suspension cells were
treated with 10 M Pu-27, mutated Pu-27 (as a control), and
CRO (as a control) for 3 days. Cells were harvested at the indi-
cated time points and washed to remove residual media. The
cells were then resuspended, fixed with 2% paraformaldehyde
in PBS at 37 °C for 10 min, and washed in 0.5% BSA-PBS and
permeabilized cells with 0.125% Triton X-100 in 0.5% BSA-PBS
for 1 min; the cells were washed with 0.5% BSA-PBS and incu-
bated with 3 g/150 ml of anti-phospho-H2AX Ser139 antibod-
ies conjugated with the FITC fluorochrome for 30 min in the
dark at room temperature. The cells were then washed to
remove excess antibody, and FITC was measured on a Becton
Dickinson FACSCalibur flow cytometer.
Chromosome and Telomere Fluorescence in Situ Hybridiza-
tion (FISH) Analysis—U937 cells were treated with Pu-27 and
CRO oligonucleotides for 2 and 5 days. Metaphases were pre-
pared by standard protocols. Briefly, cells were treated with 0.1
g/ml colcemid (Invitrogen) for 6 h, exposed to hypotonic 75
mM KCl solution for 20 min at 37 °C, and fixed in methanol:
acetic acid (3:1) three times. Slides were stained with Giemsa,
and chromosome aberrations were analyzed under a BX51
microscope (Olympus, Tokyo, Japan). A minimum of 150
metaphases were analyzed between two separate experiments
to identify chromatid- and chromosome-type aberrations.
To see the effects of Pu-27 on wild type karyotype, we
extracted peripheral blood lymphocyte from healthy donor
using HISTOPAQUE (Sigma Diagnostics, Inc.) and treated
with PHA (Invitrogen) for stimulation. For telomere FISH, the
slides with metaphase preparations were treated with 100
g/ml RNase A for 10 min at 37 °C, fixed in 4% formaldehyde,
and rinsed in PBS. The slides were denatured using 70% form-
amide/2 saline sodium citrate buffer (3 M NaCl, 0. 3 M sodium
citrate, pH 7.0) at 75 °C for 2 min, followed by dehydration in
ethanol series. Peptide-nucleic acid telomere probes (DAKO,
Carpinteria, CA) were denatured at 75 °C for 5 min. The dena-
tured probes were added to the fixed cells on slides and kept in
a hot humidified dark chamber at 37 °C for 3 h. Slides were then
washed in 70% formamide/2 saline sodium citrate buffer at
32 °C for 15 min and in sodium phosphate buffer (0.1 M
NaH2PO4, 0.1 M Na2HPO4, pH 8.0, and 0.1% Nonidet P-40) for
5 min. Slides were counterstained with DAPI, photographed
using a BX61 microscope and a cooled CCD Exi Aqua camera
(Q-imaging, BC, Canada), and scored for telomere signal loss in
75–100 metaphases.
RESULTS
Pu-27 Induces Extensive Chromosome Aberrations in U937
Cells—Karyotype analysis of U937 cells exposed to 5 M Pu-27
for up to 5 days demonstrated frequent metaphase abnormali-
ties and extensive chromosomal damage. This damage included
chromatid breaks, chromosome breaks, dicentics, and radials,
as well as extensive breaks and simple breaks (Fig. 1 and Table
1) throughout the genome including at the ends of chromo-
somes. The number of abnormal metaphases and chromo-
somal breaks were more numerous on day 2 (48.1– 63.2%) than
day 5 (31.8 –33.3%). The frequency of metaphases with simple
chromosomal breaks was also greater on day 2 (30 –39%) than
day 5 (23%) after treatment with Pu-27. Similarly, the meta-
phases exhibiting multi-radial chromosomes and extensive
chromosomal breakage was also higher at day 2 (26 –39.7%)
compared with 5-day exposure (11.4 –17.5%). Although signif-
icant numbers of cells with chromosomal abnormalities were
still present at day 5 compared with control treated cells (Table
1). The loss of telomere-specific FISH signals was also fre-
quently identified (Fig. 1D), which suggests the occurrence of
large telomeric loss. We investigated the effects of Pu-27 on
peripheral blood lymphocyte (as nontransformed WT cells)
from a healthy donor (Table 2). The effect of Pu-27 on WT
karyotypes is significantly less than it is on cancerous human
histiocytic lymphoma U937 cells. The “abnormal metaphase”
FIGURE 1. Pu-27 induces chromosomal aberrations in U937 cells. U937
cells were treated with Pu-27 for 5 days and were subjected to karyotype
analysis and telomere-specific FISH. A and B, cells treated with Pu-27 showed
extensive DNA damage throughout the chromosome. C and D, cells left
untreated (C) and cells treated with Pu-27 (D) showed numerous chromo-
somal end telomeric signals. The arrow indicates several of the abnormalities.
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and “cells with radials with extensive breaks” in malignant cells are
48–63 and 24–40%, whereas in WT cells they are 14–18 and
0–3.5%, respectively. Thus, this pronounced Pu-27-induced chro-
mosomal hypersensitivity of U937 cells suggests that DNA repair
pathways may be targeted by Pu-27 in the genome.
Pu-27 Induces Phosphorylation of H2AX—To further charac-
terize the DNA (chromosomal) damage induced by Pu-27, we
measured the induction of double-stranded breaks using phos-
phorylated H2AX (termed -H2AX) as a marker. Although it
was not present in untreated cells, -H2AX began to appear
after 6 h of exposure to Pu-27 (data not shown) and was present
throughout the treatment period. On days 1, 2, and 3, mean
-H2AX expressions in Pu-27-treated U937 cells were 22, 32,
and 28%, respectively, whereas in untreated cells mean -H2AX
expression is only 5% (Fig. 2, A and B). TRF2 is a telomere-
binding protein and is essential for t-loop formation. Overex-
pression of a dominant-negative variant of TRF2 such as (B-
TRF2) results in telomere uncapping as well as loss of the
G-rich strand (11). U937 cells transfected with B-TRF2 (B-
U937) became resistant to Pu-27 treatment (Fig. 2A). In
B-U937 cells very minimal changes (5, 5, and 2% on days 1, 2,
and 3, respectively, compared with untreated only 2%) in mean
-H2AX were observed during first 3 days of Pu-27 treatment.
These results suggest that there was an enormous induction of
-H2AX in U937 cells compared with B-U937 cells when
treated with Pu-27.
ATM Deficient Cells Are More Sensitive than ATM Proficient
Cells to Pu-27—ATM is an important upstream regulator in
DNA damage response pathway (19). TRF2 has been reported
as a direct modulator of ATM on telomeres (22–24). We sought
to investigate the sensitivity of Pu-27 in ATM proficient and
deficient mouse fibroblast cells: 4a ATM/, 695 ATM/, and
ATM 525/. Interestingly, both heterozygous and homozy-
gous ATM deficient cells (/ and /) cells were sensitive to
Pu-27, whereas ATM proficient wild type cells (ATM/) cells
were relatively resistant to Pu-27. This indicated that, in wild
type ATM/ cells, DNA damaged by Pu-27 responded well,
and cells were repaired in an ATM-dependent manner. In the
heterozygous ATM/ or homozygous ATM/ cells, repair
of Pu-27 mediated DNA damage was inefficient, leading to
chromosomal instability and cell death (Fig. 3A). 334 ATM/
cells were also resistant to Pu-27 (data not shown).
Pu-27 Induces H2AX Phosphorylation at Dysfunctional Telo-
mere by Uncapping TRF1, a Member of Shelterin Complex—Pu-27
induced extensive DNA damage throughout the chromosomes,
including telomeres. Therefore we next investigated whether
Pu-27 promotes the uncapping of telomeres. ATM deficient
mouse fibroblasts (695ATM) were more sensitive to Pu-27
compared with ATM proficient cells (4a ATM) (Fig. 3A). ATM
deficient and proficient cells were treated with 10 M Pu-27 for
2 days and were subjected to examine by confocal microscopy.
We found profound phosphorylation of -H2AX (red) probably
reflecting the presence of DSB only in ATM depleted cells. In
the same experiment, we also asked whether this phosphoryla-
tion was due to dysfunctional telomeres. Double immunofluo-
rescent staining of ATM cells was performed with TRF1
(green), a good hallmark of interphase chromosomes. Interest-
ingly, there was abundant telomere dysfunction-induced foci
co-localized with -H2AX (yellow) in Pu-27 sensitive cells. We
did not see any significant telomere dysfunction-induced foci in
ATM proficient cells (334 ATM) treated with Pu-27 (Fig. 3B).
U937 Cells Lacking the Shelterin Complex Relatively Resis-
tant to Pu-27-induced Cytotoxicity—To further assess possible
interactions between Pu-27 and the shelterin complex on
telomeres, we employed a stable cell line transfected with
B-TRF2 wherein the basic domain of TRF2, a component of
shelterin complex has been deleted (11). This B-U937 cell line
is negatively affected by the disruption of shelterin; they grow
more slowly but can nonetheless be propagated. U937 and
B-U937 cells were treated with different doses of Pu-27 and a
control oligonucleotide, mutated Pu-27, and viability was
assessed by MTT assay on day 6. U937 cells were sensitive, as we
have reported before, whereas B-U937 cells were partially
(20%) sensitive to cytotoxic effects of Pu-27 (Fig. 4A).
Annexin-PI staining of U937 cells revealed (Fig. 4B) that almost
11% cells was positive for annexin-V, PI, or both when treated
with Pu-27 for 5 days in U937 cells, and in B-U937, it was only
3%. Overall, this is an important result because the effect of
B-U937 is on the telomere shelterin complex, as well as per-
haps on the other quadruplex forming sequences throughout
TABLE 1
Chromosome aberrations of Pu-27-treated U937 cells














U937 control #1 103 3 (2.9%) 1 (1.0%) 0 1 (1.0%) 0.02
U937 control #2 93 3 (3.2%) 0 0 3 (3.2%) 0
U937 Pu-27#1 (day 2) 77 37 (48.1%) 14 (18.2%) 3 (3.9%) 20 (26.0%) 0.30
U937 Pu-27#2 (day 2) 68 43 (63.2%) 11 (16.2%) 3 (4.4%) 27 (39.7%) 0.39
U937 Pu-27#1 (day 5) 120 40 (33.3%) 7 (5.8%) 12 (10%) 21 (17.5%) 0.23
U937 Pu-27#2 (day 5) 88 28 (31.8%) 12 (13.6%) 3 (3.4%) 10 (11.4%) 0.23
TABLE 2














UNT 119 4 (3.4%) 5 (4.2%) 2 (1.7%) 0 0.06
Pu27 day 1 129 12 (9.3%) 11 (8.5%) 2 (1.6%) 0 0.1
Pu27 day 3 134 19 (14.2%) 12 (9%) 14 (10.4%) 0 0.19
Pu27 day 5 141 26 (18.4%) 27 (19.1%) 18 (12.8%) 5 (3.5%) 0.32
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the rest of the genome. This implies that the toxic effects of
Pu-27 are mediated primarily through inhibitions of telomeric
and nontelomeric function.
Pu-27-mediated Optimum Sensitivity Requires Intact Shel-
terin Complex and Not by Inhibiting Quantitative Telomerase—
Previously, we showed that human histiocytic lymphoma U937
cells were sensitive to G-quadruplex Pu-27 (22). Chromosomal
telomeric DNA consists of tandem G-rich repeats (23) and is
protected by a complex of proteins called shelterin (33, 34). We
hypothesized that the cytotoxic effects of Pu-27 to U937 cells
might be due, at least in part, to destabilization of the shelterin
protein complex. Indeed, we found that U937 cells treated with
Pu-27 showed down-regulation of key components of the shel-
terin complex TRF2, TRF1, and TIN2 (Fig. 2A; see also Fig. 6A).
Next, we tested whether the cytotoxic effects of Pu-27 might
be due, in part, to effects on telomerase. RT-PCR analysis
revealed no changes of telomerase reverse transcriptase mRNA
levels in Pu-27-treated U937 cells (see Fig. 6A). Several cell lines
do not require telomerase reverse transcriptase for mainte-
nance of telomeres. Alt (alternating lengthening of telomere)
cells have the ability to replicate indefinitely and maintain the
length of telomere in the absence of telomerase (35, 36). A549
cells require telomerase for telomere maintenance and growth
and are sensitive to Pu-27. In contrast, Sk-Lu1, an Alt cell line
that does not depend on telomerase for replication is relatively
resistant to Pu-27 (Fig. 5A).
The effect of Pu-27 on telomerase activity was further inves-
tigated by quantitative telomerase assay in U937, B-U937,
A549, and Sk-Lu-1 cells. There was no difference of telomerase
activity among Pu-27-treated and untreated cells (Fig. 5B).
These data indicate that Pu-27 perhaps exerted its sensitivity to
U937 not by reducing telomerase qualitatively but rather by
compromising the telomerase-binding site by destabilizing the
shelterin complex.
DNA Damage Response Repair Machinery Is Compromised in
Pu-27-treated U937—Pu-27 seems to disrupt the telomeric
shelterin complex (TRF2, TRF1, POT1, and TIN2) (Fig. 6A) and
may also cause DNA damage in nontelomeric regions (Fig. 1).
Next, U937 and B-U937 cells treated with Pu27 for 3 days
were analyzed for transcript levels of the molecules that regu-
late the DNA damage repair by real time RT-PCR. Down-reg-
ulation of upstream kinase ATM, DNA damage response medi-
ators (RAD17, RAD50), and DSB repair factor 53BP1 and G2
checkpoint molecules (CHK1 and CHK2) was observed. Inter-
estingly, there were no changes of DNA repair molecules
(H2AX and BRCA1) and telomere maintenance gene telomer-
ase reverse transcriptase (Fig. 6A) in U937 cells. B-U937 cells,
comparing to U937 cells presented no changes of telomeric
shelterin proteins (TRF2, TRF1, POT1, and TIN2), DNA dam-
age response mediators (RAD17 and RAD50) and DSB repair
factor 53BP1; down-regulation of upstream kinase ATM; up-
regulation of G2 checkpoint molecules (CHK1 and CHK2); and
DNA repair molecules (H2AX and BRCA1) (Fig. 6B). These
data indicate that Pu-27 resulting in DNA damage and leaving
the G2 checkpoint without repair might contribute to cellular
death.
Pu-27-treated Cellular Sensitivity Is Independent of p53—
p53 is considered as one of the most important molecule regu-
lating ATM-mediated DNA damage response and cellular
death. Therefore we investigated the role of p53 in Pu-27-reg-
ulated cell death. HCT116 cells with heterozygous and
homozygous deletion of p53 were treated with Pu27 showing
resistance to Pu27, irrespective of the presence or absence of
p53 (Fig. 7).
DISCUSSION
The G-rich quadruplex including Pu-27, enters cells (13) and
prompts extensive chromosomal damage. The DNA damage
FIGURE 2. Pu-27 induces phosphorylation of H2AX (H2AX). U937 cells and
B-U937 cells treated with Pu-27 and were subjected to Western blot and
FACS analysis. A, 3-day treatment of Pu-27 showed profound up-regulation of
H2AX expression in U937 cells but almost no changes in dB-U937 cells. Rel-
ative expressions of TRF2 in U937 and B-U937 cells were also shown. TRF2
expression is down-regulated in U937 cells and no changes in B-U937 cells
when treated with Pu-27 (consistent with RT-PCR data in Fig. 6). Bottom panel,
relative expression presented in bar graphs. *, p 	 0.05. B, by FACS analysis
H2AX has shown continued to be highly expressed from days 1–3, and again
there was no significant change in B-U937 cells. Bottom panels, relative
expression presented in bar graphs. *, p 	 0.05.
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appears to be predominantly in the form of double-stranded
breaks as reflected by increases in phosphorylated H2AX. We
noticed extensive breaks throughout the chromosome comple-
ment following exposure to Pu-27. We also found breaks
involved at the telomeric end of the chromosome (Fig. 1D) by
FISH as evident by less FISH positive chromosome and more
FISH positive chromatid in Pu-27-treated cells. During pro-
longed incubations, we observed greater disruption of chromo-
somes and chromatids on day 2 versus day 5, perhaps because
cells with extensive damage died early on (Table 1). Cells sense
disruption of the shelterin protein complex as double-stranded
breaks (33). It has been reported that a small molecule can alter
the shelterin integrity and trigger DNA damage response at
telomeres (34).
Here, we showed for the first time that a natural G-quad-
ruplex, Pu-27, an important regulator of c-Myc transcription
(24), preferentially damages telomeres, partly by disrupting
and dismantling the shelterin complex, which is a natural
protector of telomeres. One of the mechanisms of cell death
caused by Pu-27 is most likely caused by disruption of telom-
ere function/replication. This idea is supported by three
main lines of evidences. First, cells that do not depend on
telomerase for telomere replication (i.e., alternative length-
ening of telomeres) are relatively resistant to the effects of
Pu-27. Second, direct quantitation of telomeres in Pu-27-
treated cells indicates the loss of several FISH-positive chro-
mosomal ends. Third, introduction of a dominant-negative
member of the shelterin complex in U937 cells B-U937
cells, where the N-terminal TRF2 basic domain is deleted,
mostly prevents Pu-27-induced cell death. These latter
results suggest that an intact shelterin complex is required
for the “anti-telomeric” action of Pu-27.
FIGURE 3. A, ATM deficient cells are more sensitive to Pu-27. MTT assay was done in 4a ATM/, 695 ATM/, and 525 ATM/ cells derived from mice treated
with Pu-27 and showed that both hetero- and homozygous cells are sensitive, but not wild type cells. *, p values for 695 ATM/ and 525 ATM/ are 	 0.001,
respectively, and that for 334 ATM/ is 0.145 at 10 M of Pu-27 treatment. B, Pu-27-induced H2AX phosphorylation (H2AX) at dysfunctional telomere by
uncapping TRF1, a member of shelterin complex. 695 ATM/ and 334 ATM/ cells treated with Pu-27 for 2 days and immunostained with TRF1 (green) and
-H2AX (red). Co-localization of TRF1 with -H2AX in ATM deficient cells represents the presence of telomere dysfunction-induced foci, which suggests that
Pu-27 destabilizes telomere-shelterin homeostasis.
DNA Damage Response by G-quadruplex Pu27
8526 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289 • NUMBER 12 • MARCH 21, 2014
On the other hand, cytogenetic analysis of Pu-27-treated
cells shows clear evidence of chromosomal breakage in nonte-
lomeric regions. Whether this damage is a result of interference
with the replication of G-rich quadruplex regions of the DNA
or mechanical disruption secondary to nondysjunction of
telomeres is not clear.
Previously, we argued that Pu-27-mediated cell killing
involved interference with c-Myc transcription (24). c-Myc is a
proto oncogenic transcription factor related to tumor growth
in a number of mouse models (35). Its overexpression causes
cell death in fibroblast and myeloid cell lines (36) and induces
apoptosis by producing oxidative stress in hepatic cells (37) and
inhibition of c-Myc expression sensitizes to TNF-induced apo-
ptosis (38). Therefore, interference with c-Myc expression
remains a viable alternative to that of inhibition of telomere
replication. Regardless of the precise mechanism(s) involved in
Pu-27 cytotoxicity, it clearly does not involve p53-dependent
cell death in as much as Pu-27 sensitivity in HCT116 cells is not
affected by the presence or absence of p53. The exact mecha-
nism by which Pu-27 causes dysfunction in the c-Myc promoter
or the telomere shelterin complex is not known. Indeed, the
two effects could be related; multiple levels of evidence suggest
that c-Myc has some role in chromosomal rearrangement and
remodeling through the telomere (39), and there is direct inter-
FIGURE 4. Pu-27 induces significant cell death in U937 cells but not in dB-U937 cells. A, MTT assay of U937 and B-U937 cells shows U937 cells are sensitive,
and B-U937 cells are relatively resistant to Pu-27. CRO is used as a control. *, p 	 0.002 at 10 M of Pu-27 treatment. B, U937 and B-U937 cells were treated
with Pu-27 for 4 and 5 days, and dead cells were measured with annexin/PI staining. Almost 10% of cells are positive for annexin, PI, and annexin-PI in U937 cells,
but few cells were positive in 
-U937 cells, at least after 5 days of treatment. *, p 	 0.001 in both days 4 and 5.
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action of c-Myc with catalytic subunit of telomerase (40). The
G-quadruplex-interactive telomerase inhibitor, telomestatin
(SOT-095), in combination with imatinib has been shown
effective against leukemia (41) and the anti-leukemic effect
could conceivably involve interference with c-Myc expression,
telomerase activity, or both. Quantitative telomerase activity in
cell lysates pretreated with Pu-27 exposed that Pu-27 at least
does not quantitatively interfere with the telomerase activity of
both Alt and non-Alt cells (Fig. 5B). However, whether Pu-27
can interfere with telomerase activity qualitatively and quanti-
tatively in single cellular level remains to be investigated. Can-
cer therapy directed against telomerase results in cells being
mitochondrially adapted and modified with an alternate path-
way to lengthening cells (37). Pu-27 could potentially be a good
therapeutic strategy for cancer treatment because it appeared
to be not directly inhibiting telomerase.
ATM deficient cells are more sensitive to Pu-27 (Fig. 3A) and
exhibit abundant telomere dysfunction-induced foci (Fig. 3B).
The precise mechanism(s) by which Pu-27 exerts its sensitivity
in these ATM deficient cells are not quite explored. ATM is an
upstream key regulator of DNA damage response pathways.
Therefore, it would be normal to expect that ATM deficient
cells are unable to repair the DNA damage properly and are
more vulnerable to Pu-27 treatment. The shelterin complex is
also not properly protected in ATM deficient cells, making
them more susceptible to a DNA-damaging agent like Pu-27.
The concept of synthetic lethality (42) in the context of cancer
therapy provides a conceptual framework for the cancer-spe-
FIGURE 5. Pu-27 exerted its sensitivity through intact shelterin complex and not by inhibiting telomerase qualitatively. A, Sk-Lu-1, an Alt lung cancer cell
line, is relatively resistant to Pu-27, whereas A549 non-Alt lung cancer cell line is sensitive to Pu-27. *, p 	 0.003 at 10 M of Pu-27 treatment. B, telomerase
activity in Alt (Sk-Lu-1), non-Alt (A549), U937, and B-U937 cells after treatment of Pu-27 (PU) and CRO (as a control). Statistical analysis on the relative
telomerase activities among various treatments has been performed with the 2 test for independence. Among control and Pu-27-treated A549, Sk-Lu-1 (Alt
cells) cells, H0 cannot be rejected, p  0.97; among control and Pu-27-treated U937 and dB cells, H0 cannot be rejected, p  0.925; these results signify no
difference among the various groups.
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FIGURE 6. Pu-27 inhibits the molecules related to DNA damage repair machinery in U937. A, RT-PCR of U937 and B-U937 cells treated with Pu-27 for 3
days. Pu-27 inhibits ATM, RAD17, RAD50, CHK14, and CHK2 but not H2AX, BRCA1, and telomerase reverse transcriptase in U937 cells. B, B-U937 cells showed
no changes of TRF2, TRF1, POT1, TIN2, RAD17, RAD50, and 53BP1; down-regulation of ATM; up-regulation of CHK1 and CHK2; and H2AX and BRCA1.
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cific cytotoxic agent. G-quadruplex DNA has been shown as a
molecular target for induction of synthetic lethality in cancer
cells (13). It would be interesting to see whether ATM gene is
synthetically lethal to c-Myc or any other genes targeted by
Pu-27.
In general, telomerase is more active in cancer cells than
normal quiescent cells (31). This may represent an opportunity
for the development of agents similar to Pu-27. The apparently
greater dependence of cancer cells on telomerase activity may
suggest that agents that interfere with this crucial enzymatic
activity have real promise for the development of new thera-
pies. Lastly, we have addressed the role of p53 in Pu-27-medi-
ated DNA damage response. It has been postulated that DNA
damage response pathway might facilitate tumor suppression
by triggering p53 in response to persistent DNA injury and
genomic instability that attends tumor progression (32). We
have shown that Pu-27 sensitivity in HCT116 cells is not corre-
lated with the presence or absence of p53 (Fig. 7), suggesting
that the effect of Pu-27 is p53-independent.
Our results demonstrate that the G-quadruplex sequence of
the c-Myc promoter region, Pu-27, disrupts shelterin complex
at the telomere region in addition to causing extensive damage
throughout the chromosome. The Pu-27-treated cells sense
these telomeric and nontelomeric double-stranded breaks and
are unable to repair them because of suppression of DNA repair
machinery leading to p53-independent cell death (Fig. 8).
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